Governance
Governing Board
The Governing Board is composed of one representative from each partner and it is responsible for driving forward the strategic direction of the organization ensuring the performance of the project and managing risk and accountability.
Steering Committee
The Steering Committee’s role is to ensure the scientific cohesion as well as the delivery and achievement of the project outcomes providing advice, support and guidance. It implements decision taken by the Governing Board and can also propose adapted actions to problems encountered. This Committee is composed of all work package leaders and the principal investigator of each team (if not represented as WP leaders).
Scientific Advisory Board (SAB)
The Scientific Advisory Board is represented by scientific external members who also are international experts. The SAB is able to advice the consortium on scientific, medical or social issues. It is responsible for assessing the overall scientific relevance of the project as well as putting into perspective the scientific objectives of the project and its progress.
Pr Jérôme Honnorat
(Coordinator and WP1,3,6 leader)
Institut MeLiS, Lyon, France
Dr Lars Komorowski
Responsable WP2
Euroimmun, Lübeck, Allemagne
Dr Agusti Alentorn
WP4 partner
Institut du Cerveau et de la Moelle épinière, Paris, France
Dr Bertrand Dubois
WP4 leader
Centre de Recherche en Cancérologie de Lyon, France
Pr Roland Liblau
WP5 leader
Centre de physiopathologie de Toulouse-Purpan France
Pr Delphine Maucort-Boulch
WP6 partner
Laboratoire de Biométrie et d'Evolution Biologique Lyon, France
Pr Pierre Coulie
Institute de Duve, University Catholic of Louvain, Belgium
Dr Agnes Lehuen
Institut Cochin, Paris, France
Dr Frank Leypoldt
University Hospital Schleswig-Holstein, Germany
Pr Josep Dalmau
University Clinic Hospitalof Barcelona, Spain
Dr Romana Höftberger
(SAB president), Institute of Neurology, Medical University of Vienna, Austria